scispace - formally typeset
D

Dennis B. Lubahn

Researcher at University of Missouri

Publications -  201
Citations -  29869

Dennis B. Lubahn is an academic researcher from University of Missouri. The author has contributed to research in topics: Estrogen receptor & Estrogen receptor alpha. The author has an hindex of 79, co-authored 200 publications receiving 28809 citations. Previous affiliations of Dennis B. Lubahn include Mayo Clinic & University of Missouri System.

Papers
More filters
Journal ArticleDOI

Estrogen Inhibits Cardiac Hypertrophy: Role of Estrogen Receptor-β to Inhibit Calcineurin

TL;DR: E2 acting mainly through ERbeta mitigates the important signaling by AngII that produces cardiac hypertrophy and fibrosis in female mice and substantially prevented ventricular interstitial cardiac fibrosis as induced by Ang II.
Journal ArticleDOI

Intraovarian actions of oestrogen

TL;DR: Microarray technologies, combined with specific hormone treatment regimens are likely to provide an attractive, alternative approach to using mutant mice in clarifying the direct actions of oestrogen in the ovaries of other species.
Journal ArticleDOI

Paracrine Regulation of Epithelial Progesterone Receptor by Estradiol in the Mouse Female Reproductive Tract

TL;DR: Analysis of estrogen receptor alpha (ERalpha) knockout mice showed that ERalpha is essential for E(2))-induced PR expression in both vaginal epithelium and stroma, and for E (2)-induced down-regulation, but not constitutive expression of PR in uterine epithelia.
Journal ArticleDOI

Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification.

TL;DR: E2-induced vaginal epithelial proliferation is mediated indirectly through stromal ER alpha, consistent with the recent findings in uterus, and the first known functions attributed to epithelial ER alpha in vivo are attributed.
Journal ArticleDOI

Estrogen receptor-beta prevents cardiac fibrosis.

TL;DR: The results establish the cardiac fibroblast as an important target for hypertrophic/fibrosis-inducing peptides the actions of which were mitigated by E2/ERβ acting in these stromal cells.